Kwality Pharmaceuticals Ltd banner

Intrinsic Value

The intrinsic value of Kwality Pharmaceuticals Ltd (KPL) under the Base Case is 822.27 INR per share. Compared with the current market price of 4 048.4 INR, the stock appears Overvalued by 80% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

KPL Intrinsic Value
₹822.27
Overvaluation 80%
Intrinsic Value
Price ₹4 048.4
Alert me when KPL is below its intrinsic value
Today ₹657.82 · 83.8% below the current price

We don’t have enough historical valuation data to make this comparison.

Alternatives to KPL

Fundamental Analysis

What Kwality Pharmaceuticals Does

Pharmaceuticals Health Care

Kwality Pharmaceuticals makes finished medicines. It turns active drug ingredients into products such as tablets, capsules, syrups, and injections, then sells them to hospitals, pharmacies, distributors, and other medicine buyers in India and overseas. The company earns money mainly by manufacturing and selling these drug products, sometimes under its own brands and sometimes for other companies.

Headquarters
India IN
IPO date
Jul 18, 2016
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue KPL Research

Decided on Kwality Pharmaceuticals? Get an email when KPL reaches the price you’d buy at. Free with an account.

Other Kwality Pharmaceuticals listings

What is the Intrinsic Value of one KPL stock?

The intrinsic value for Kwality Pharmaceuticals Ltd (KPL) under the Base Case is 822.27 INR.

Is KPL stock undervalued or overvalued?

Compared with the current market price of 4 048.4 INR, the stock appears Overvalued by 80% .

How reliable are our estimates? See how past valuations played out
Back to Top